Free Trial

Refined Wealth Management Buys 106,843 Shares of Enovix Corporation (NASDAQ:ENVX)

Enovix logo with Energy background

Refined Wealth Management increased its stake in shares of Enovix Corporation (NASDAQ:ENVX - Free Report) by 18.8% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 675,449 shares of the company's stock after purchasing an additional 106,843 shares during the period. Enovix makes up 4.1% of Refined Wealth Management's investment portfolio, making the stock its 11th largest holding. Refined Wealth Management owned 0.35% of Enovix worth $4,958,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Vanguard Group Inc. raised its stake in Enovix by 15.1% during the 4th quarter. Vanguard Group Inc. now owns 15,773,464 shares of the company's stock valued at $171,458,000 after buying an additional 2,063,631 shares during the last quarter. Electron Capital Partners LLC increased its position in Enovix by 0.5% during the fourth quarter. Electron Capital Partners LLC now owns 5,658,734 shares of the company's stock valued at $61,510,000 after acquiring an additional 29,109 shares during the last quarter. Geode Capital Management LLC increased its position in Enovix by 6.6% during the fourth quarter. Geode Capital Management LLC now owns 3,818,827 shares of the company's stock valued at $41,520,000 after acquiring an additional 235,142 shares during the last quarter. Royal Bank of Canada lifted its holdings in Enovix by 1.5% in the fourth quarter. Royal Bank of Canada now owns 1,933,073 shares of the company's stock valued at $21,012,000 after acquiring an additional 28,591 shares during the period. Finally, Fred Alger Management LLC boosted its position in Enovix by 212.4% in the fourth quarter. Fred Alger Management LLC now owns 1,838,914 shares of the company's stock worth $19,989,000 after purchasing an additional 1,250,300 shares during the last quarter. Institutional investors own 50.92% of the company's stock.

Enovix Stock Down 3.2%

Shares of ENVX stock opened at $8.23 on Friday. The company has a debt-to-equity ratio of 0.71, a current ratio of 4.68 and a quick ratio of 4.49. Enovix Corporation has a one year low of $5.27 and a one year high of $18.68. The company's fifty day moving average price is $7.41 and its 200-day moving average price is $8.88. The company has a market capitalization of $1.58 billion, a price-to-earnings ratio of -6.38 and a beta of 2.00.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on ENVX. JPMorgan Chase & Co. reduced their price target on shares of Enovix from $10.00 to $9.00 and set an "overweight" rating for the company in a research report on Thursday, May 1st. Benchmark cut their target price on shares of Enovix from $25.00 to $15.00 and set a "buy" rating for the company in a research report on Tuesday, April 15th. TD Securities decreased their price target on shares of Enovix from $10.00 to $7.00 and set a "hold" rating on the stock in a research report on Thursday, May 1st. Finally, B. Riley dropped their price target on shares of Enovix from $17.00 to $12.00 and set a "buy" rating on the stock in a research note on Tuesday, April 29th. Three investment analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $17.27.

Read Our Latest Report on ENVX

About Enovix

(Free Report)

Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

Featured Articles

Institutional Ownership by Quarter for Enovix (NASDAQ:ENVX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Enovix Right Now?

Before you consider Enovix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovix wasn't on the list.

While Enovix currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Bought This Stock at the Bottom—Will You Miss It?
The Drone Industry Is About to 10X—Here’s How to Profit
Why AMD Stock Beats NVIDIA Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines